These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


11257 related items for PubMed ID: 10685653

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma.
    Legha SS, Ring S, Eton O, Bedikian A, Buzaid AC, Plager C, Papadopoulos N.
    J Clin Oncol; 1998 May; 16(5):1752-9. PubMed ID: 9586888
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
    Daponte A, Ascierto PA, Gravina A, Melucci MT, Palmieri G, Comella P, Cellerino R, DeLena M, Marini G, Comella G, Italian Cooperative Oncology Group.
    Cancer; 2000 Dec 15; 89(12):2630-6. PubMed ID: 11135225
    [Abstract] [Full Text] [Related]

  • 25. Chemotherapy and chemoimmunotherapy in disseminated malignant melanoma.
    Garbe C.
    Melanoma Res; 1993 Aug 15; 3(4):291-9. PubMed ID: 7693093
    [Abstract] [Full Text] [Related]

  • 26. Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.
    Kim KB, Eton O, East MJ, Hodges C, Papadopoulos NE, Grimm EA, Bedikian AY.
    Cancer; 2004 Aug 01; 101(3):596-603. PubMed ID: 15274073
    [Abstract] [Full Text] [Related]

  • 27. Current therapy for malignant melanoma.
    Legha SS.
    Semin Oncol; 1989 Feb 01; 16(1 Suppl 1):34-44. PubMed ID: 2465575
    [Abstract] [Full Text] [Related]

  • 28. The role of interleukin-2 in the management of stage IV melanoma: the EORTC melanoma cooperative group program.
    Keilholz U, Eggermont AM.
    Cancer J Sci Am; 2000 Feb 01; 6 Suppl 1():S99-103. PubMed ID: 10685668
    [Abstract] [Full Text] [Related]

  • 29. Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe.
    Negrier S, Maral J, Drevon M, Vinke J, Escudier B, Philip T.
    Cancer J Sci Am; 2000 Feb 01; 6 Suppl 1():S93-8. PubMed ID: 10685667
    [Abstract] [Full Text] [Related]

  • 30. Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group.
    Atkins MB, Hsu J, Lee S, Cohen GI, Flaherty LE, Sosman JA, Sondak VK, Kirkwood JM, Eastern Cooperative Oncology Group.
    J Clin Oncol; 2008 Dec 10; 26(35):5748-54. PubMed ID: 19001327
    [Abstract] [Full Text] [Related]

  • 31. Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma.
    Guida M, Riccobon A, Biasco G, Ravaioli A, Casamassima A, Freschi A, Palma MD, Galligioni E, Nortilli R, Chiarion-Sileni V, Picozzo J, Romanini A, Nanni O, Ridolfi R, Italian Melanoma Intergroup (IMI).
    Melanoma Res; 2006 Aug 10; 16(4):317-23. PubMed ID: 16845327
    [Abstract] [Full Text] [Related]

  • 32. Complex combination biochemotherapy regimen in advanced metastatic melanoma in a non-intensive care unit: toxicity or benefit?
    Hofmann MA, Sterry W, Trefzer U.
    Jpn J Clin Oncol; 2007 Mar 10; 37(3):224-9. PubMed ID: 17472972
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study.
    Neri B, Vannozzi L, Fulignati C, Pantaleo P, Pantalone D, Paoletti C, Perfetto F, Turrini M, Mazzanti R.
    Cancer Invest; 2006 Mar 10; 24(5):474-8. PubMed ID: 16939954
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 563.